Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor A like 5 (TCEAL5) is a nuclear protein encoded on the X chromosome that belongs to the TCEAL/Transcription elongation factor A (SII)-like gene family, characterized by the presence of a BEX (brain expressed X-linked-like) domain[1][3]. TCEAL5 may be involved in the regulation of transcriptional elongation, based on family homology, but its precise molecular function remains unclear[1][3]. Experimental evidence in mouse models indicates that Tceal5 acts as a positive regulator of cell proliferation, with elevated expression in pituitary tumors and certain proliferative contexts[4]. Overexpression of Tceal5 in pituitary progenitor cells increases cell proliferation and may contribute to adenoma formation, suggesting a context-specific proto-oncogenic role[4]. No confirmed drugs are known to directly interact with TCEAL5, and it is not an established therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation factor A like 5 (TCEAL5).